Dr. Stephen Brian Leblanc, MD

Dr. Leblanc practices at Mississippi Asthma & Allergy Clinic PA in Meridian, Mississippi.

Dr. Leblanc's NPI, 1679837066, was assigned on June 29, 2012. Dr. Leblanc graduated from University of Mississippi School of Medicine in 2012. Dr. Leblanc holds Mississippi license 23514.

Dr. Leblanc's primary practice is Mississippi Asthma & Allergy Clinic PA, at 3704 Hwy 39 N, Meridian, MS 39301 in Lauderdale County. The practice phone is (601) 354-4836.

Dr. Leblanc's primary practice is Mississippi Asthma & Allergy Clinic PA in Meridian, Mississippi. Dr. Leblanc is also affiliated with Baptist Anderson Regional Medical Center. The medical group on file is University of Mississippi Medical Center. Dmand AI also links Dr. Leblanc to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Leblanc practices, 2 sites in all. Vendor and product names are available with a free account.

Allergy and immunology is Dr. Leblanc's primary specialty in the NPI Registry, under taxonomy code 207RA0201X. Dr. Leblanc is licensed in Mississippi.

CMS data shows 9,423 Medicare services from Dr. Leblanc across 10 procedure codes in 2024, for 283 Medicare patients. Medicare paid $223,349 for them. Every service was in an office.

CMS counts 283 Medicare patients who saw Dr. Leblanc in 2024. The largest group is 65 to 74, with 152 patients. 75% of them have high blood pressure, and 71% have high cholesterol. 8% are also on Medicaid. Their average risk score is 0.95, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Leblanc's median patient age at 28, with 60% women.

In 2024, Dr. Leblanc wrote 2,201 Medicare Part D claims for 314 patients. 81% of them were for generic drugs. CMS names the drug for 2,055 of them, across 27 drugs with 11 or more claims each, at $274,588 in total drug cost. In 2023, CMS named 1,669 claims across 27 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Leblanc for performance year 2024, reported as part of a group.

Dmand AI links 2 papers to Dr. Leblanc, published from 2015 to 2021. Dr. Leblanc's most frequent co-authors are Douglas Thomas Johnston, DO, Kathryn Lindsey McMullan, MD and Marc Andrew Riedl, MD.

CMS Open Payments shows 522 general payments to Dr. Leblanc from 32 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 32% of the total. CSL Behring paid the most, $13,555.

Dr. Leblanc graduated from University of Mississippi School of Medicine in 2012.